Qu Biologics Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 54
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $48.8K
Latest Deal Amount
  • Investors
  • 4

Qu Biologics General Information

Description

Developer of a site specific immunotherapy designed to restore the body's normal immune function to treat cancer and other immune-related diseases. The company's immunotherapy utilizes built-in knowledge to direct an activated innate immune response to specific organs or tissues to respond productively to any pathology that may be present at that body site and it contains components from a single inactivated microbial species that the immune system recognizes as a common cause of infection in a specific organ or tissue, enabling medical researchers to develop therapy that can activate and train human immune system to fight cancer and other diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 4475 Wayburne Drive
  • Suite 305
  • Burnaby, British Columbia V5G 4X4
  • Canada
+1 (604) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Qu Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Angel (individual) 04-Jun-2018 $48.8K 000.00 Completed Clinical Trials - Phase 2
7. Angel (individual) 12-Apr-2016 00.000 000.00 Completed Clinical Trials - Phase 2
6. Grant 06-Apr-2016 00000 000.00 Completed Clinical Trials - Phase 2
5. Angel (individual) 23-Dec-2015 00.000 000.00 Completed Generating Revenue
4. Angel (individual) 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 17-Sep-2014 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 01-Jun-2012 $4.93M $4.93M Completed Startup
1. Grant 25-May-2012 $3.09M Completed Startup
To view Qu Biologics’s complete valuation and funding history, request access »

Qu Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a site specific immunotherapy designed to restore the body's normal immune function to treat cancer and oth
Biotechnology
Burnaby, Canada
54 As of 2016
000.00
0000000000 000.00

00 00000

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
0000000000000
Glasgow, United Kingdom
00 As of 0000
000.00
000 0000-00-00
0000000000 0 000.00

000000 0

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qu Biologics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TC Biopharm Venture Capital-Backed Glasgow, United Kingdom 00 000.00 0000000000 0 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000000000 0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 00000000000 00000
00000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Qu Biologics Executive Team (8)

Name Title Board Seat Contact Info
Hal Gunn MD Chief Executive Officer, Board Member & Co-Founder
David Mullins Ph.D Chief Scientific Officer
Rob Freeman Co-Founder
Bob Cory Vice President, Business Development
Jim Pankovich Vice President, Clinical Operations & Drug Development
You’re viewing 5 of 8 executive team members. Get the full list »

Qu Biologics Board Members (6)

Name Representing Role Since
Hal Gunn MD Qu Biologics Chief Executive Officer, Board Member & Co-Founder 000 0000
Julia Levy Ph.D Self Board Member 000 0000
Karn Manhas Qu Biologics Board Member 000 0000
Michael Leschuk Qu Biologics Board Member 000 0000
Robert Pelzer Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Qu Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qu Biologics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Genome British Columbia Not-For-Profit Venture Capital 000 0000 000000 0
Julia Levy Angel (individual) Minority 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
The Scientific Research and Experimental Development Government 000 0000 000000 0
To view Qu Biologics’s complete investors history, request access »